Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 14, 2019
Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in SpainB Castelo, D Viñal, R Maseda, et al.
Journal of Immunological Methods|December 5, 2021
Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissueZuwena A Richardson, Claire Deleage, Candani S A Tutuka, et al.
Mbio|March 30, 2026
HIV Nef-mediated WAVE2-ARP2/3 inhibition underlies CD4<sup>+</sup> T-cell lamellipodial abnormalities and immune dysfunctionDaniel C Dunn, Jacqueline M Crater, Perla M Del Río Estrada, et al.
The British Journal of Dermatology|January 30, 2019
Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatosesE Chacón-Solano, C León, F Díaz, et al.
Neurologia|May 22, 2025
Variables associated with cognitive alterations in a cohort of COVID-19 survivors at a tertiary hospital in MexicoM Rodríguez-Rodríguez, Y Rodríguez-Agudelo, F J Soto-Moreno, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|August 22, 2019
Trends of maxillofacial trauma: An update from the prospective register of a multicenter study in emergency services of ChileF Werlinger, M Villalón, V Duarte, et al.
The British Journal of Dermatology|June 1, 2011
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplexM García, J L Santiago, A Terrón, et al.
Science Translational Medicine|January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodiesConstantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.
Molecular Medicine (Cambridge, Mass.)|November 8, 2022
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trialSergio Fragoso-Saavedra, Isaac Núñez, Belem M Audelo-Cruz, et al.
Pageof 10